Is CYRWF or MRK a better dividend investment in 2026?

CYRWF currently yields 3333.33% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: CYRWF offers higher current income.

What is the dividend yield difference between CYRWF and MRK?

CYRWF has a forward dividend yield of 3333.33% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 3330.57 percentage points.

Home › Compare › CYRWF vs MRK

CYRWF vs MRK: Dividend Comparison 2026

CYRWF yields 3333.33% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CYRWF wins by $1244041712890.34M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CYRWF

● Live price

3333.33%

Share price

$0.06

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1244041712890.40M

Annual income

$1,174,716,366,071,938,000.00

Full CYRWF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — CYRWF vs MRK

📍 CYRWF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CYRWF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CYRWF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CYRWF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CYRWF

Annual income on $10K today (after 15% tax)

$283,333.33/yr

After 10yr DRIP, annual income (after tax)

$998,508,911,161,147,300.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, CYRWF beats the other by $998,508,911,161,139,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CYRWF + MRK for your $10,000?

CYRWF: 50%MRK: 50%

100% MRK50/50100% CYRWF

Portfolio after 10yr

$622020856445.23M

Annual income

$587,358,183,035,973,900.00/yr

Blended yield

94.43%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CYRWF

No analyst data

Altman Z

84.5

Piotroski

1/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CYRWF buys

MRK buys

No recent congressional trades found for CYRWF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCYRWFMRK

Forward yield	3333.33% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$1244041712890.40M ✓	$56.8K
Annual income after 10y	$1,174,716,366,071,938,000.00 ✓	$9,798.13
Total dividends collected	$1239274250481.68M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CYRWF vs MRK ($10,000, DRIP)

Year	CYRWF Portfolio	CYRWF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$344,033	$333,333.33	$11,206	$366.19	+$332.8K → CYRWF
2	$11,085,665	$10,717,549.33	$12,650	$502.35	+$11.07M → CYRWF
3	$334,616,633	$322,754,971.08	$14,407	$694.19	+$334.60M → CYRWF
4	$9,462,934,690	$9,104,894,892.71	$16,585	$967.82	+$9462.92M → CYRWF
5	$250,766,259,005	$240,640,918,887.41	$19,342	$1,363.89	+$250766.24M → CYRWF
6	$6,228,082,462,189	$5,959,762,565,053.11	$22,913	$1,947.19	+$6228082.44M → CYRWF
7	$144,998,525,500,125	$138,334,477,265,582.72	$27,662	$2,823.89	+$144998525.47M → CYRWF
8	$3,165,074,899,913,431	$3,009,926,477,628,297.00	$34,159	$4,173.35	+$3165074899.88M → CYRWF
9	$64,790,043,755,570,470	$61,403,413,612,663,110.00	$43,337	$6,308.80	+$64790043755.53M → CYRWF
10	$1,244,041,712,890,398,500	$1,174,716,366,071,938,000.00	$56,776	$9,798.13	+$1244041712890.34M → CYRWF

CYRWF vs MRK: Complete Analysis 2026

CYRWF — Stock

Canyon Resources Limited, together with its subsidiaries, engages in the development and exploration of bauxite properties and engineering studies in West Africa. Its flagship property is the 100% owned Minim Martap Bauxite project located in central Cameroon. The company was formerly known as Castlemaine Resources Limited and changed its name to Canyon Resources Limited in March 2010. Canyon Resources Limited was incorporated in 2009 and is based in West Perth, Australia.

Full CYRWF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this CYRWF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CYRWF vs SCHD CYRWF vs JEPI CYRWF vs O CYRWF vs KO CYRWF vs MAIN CYRWF vs JNJ CYRWF vs ABBV CYRWF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.